FDA Clears DermaSensor’s AI Skin-Cancer Scanner for Primary Care, Citing 96% Sensitivity
A pocket-sized device that reads suspicious moles the way a specialist might has now been cleared by the U.S. Food...
Month: September 2026
Aureka Biotechnologies Raises $100 Million to Build a ‘Biological World Model’ for Antibody Design
Aureka Biotechnologies closed a $100 million Series B on August 10, 2026, pushing the AI-native drug discovery startup's total funding...
Minnesota Judge Orders UnitedHealth to Turn Over Files on AI Tool Accused of a 90% Error Rate
A federal judge in Minnesota dealt UnitedHealth Group one of its most damaging legal setbacks in years on March 9,...
California’s SB 243 Forces AI Companion Chatbots to Detect Suicidal Ideation or Face Lawsuits
Since January 1, 2026, any company operating an AI companion chatbot available to Californians has been legally required to detect...
Penn’s ApexGO AI Turns Weak Antibiotic Candidates Into Drugs That Match Polymyxin B in Mice
A generative AI system built at the University of Pennsylvania is tackling one of drug discovery's most stubborn problems: taking...
J&J’s OTTAVA Robot Completes First Human Trial With Zero Conversions to Open Surgery
Johnson & Johnson announced on May 5, 2026 the results of the first clinical study of its investigational OTTAVA Robotic...
Viz.ai Data Show AI Platform Cut Stroke Transfer Times 44% at a Regional California Hospital Network
Viz.ai, the AI-powered stroke care coordination company, presented data at the American Heart Association's International Stroke Conference in early 2026...
Isomorphic Labs Raises $2.1 Billion Series B to Push Its AI Drug Design Engine Toward Human Trials
Isomorphic Labs, the Alphabet-owned AI drug discovery company built on the legacy of DeepMind's AlphaFold research, announced on May 12,...
Google and AMILI’s New App Skips Calorie Counting for Gut-Microbiome-Based Nutrition Advice
Google is teaming up with Singapore-based microbiome company AMILI to launch a personalized nutrition app called AMILI Optimise, one that...
Woebot’s Shutdown Exposes the Gap Between Fast AI and Slow FDA Approval for Therapy Chatbots
Woebot Health, one of the earliest and best-known AI therapy chatbots, shut down its consumer cognitive behavioral therapy (CBT) service...
